NYSE$AMN

AMN Healthcare Services Inc. · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

AMN Healthcare announced Q4 2023 results with revenue of $818 million and adjusted EPS of $1.32.

AMN Healthcare's Q4 2023 revenue was $818 million, a 27% decrease year-over-year and 4% lower than the prior quarter. GAAP EPS was $0.33, and adjusted EPS was $1.32. The company is focused on technology-centric total talent solutions and consolidating businesses under the One AMN platform.

  • Consolidated revenue for the quarter was $818 million, a 27% decrease year over year.
  • Net income was $12 million, or $0.33 per diluted share, compared to $82 million, or $1.88 per diluted share, in the same quarter last year.
  • Adjusted diluted EPS was $1.32 compared with $2.48 in the year-ago quarter.
  • The MSDR acquisition closed in late November and contributed revenue of $13 million for the quarter.

Headline financials

Total Revenue

$818M

Previous: $1.13B-27.3%
EPS (adj)

$1.32

Previous: $2.48-46.8%
Capital Expenditures

$29.9M

Previous: $24.6M+21.4%
Free Cash Flow

-$71M

Previous: $89M-179.8%
Net Income

$12M

Previous: $82M-85.4%
Operating Income

$34M

Previous: $119M-71.4%
Gross Profit

$220M

Previous: $375M-41.4%
Stock-Based Comp

$2.58M

Previous: $5.4M-52.2%

Revenue & EPS history

AMN Healthcare · Revenue · Quarterly

$818M

Q4 2023-27.3%vs Q4 2022
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

AMN Healthcare · $748M total across 3 segments · Q4 2025

  • Nurse & Allied Solutions
    $491M
  • Physician & Leadership
    $170M
  • Technology & Workforce
    $88M

Forward guidance

Consolidated revenue in the first quarter of 2024 is projected to be 26-28% lower than the year-ago period.

Headwinds

  • Nurse and Allied Solutions segment revenue is expected to be down 36-38% below prior year.
  • Technology and Workforce Solutions segment revenue is projected to be down 18-20% year over year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-0.0%

Avg return

Earnings day

-1.9%

Avg return

5 days after

-0.6%

Avg return

30 days after

52%

34 / 66 earnings

Positive

+29.2%

Q1 2026

Best reaction

-29.5%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+29.2%+38.5%+41.5%
Q4 2025+11.4%+15.8%+4.2%
Q3 2025-3.4%-10.0%-11.8%
Q2 2025+2.3%+10.2%+23.2%
Q1 2025+8.2%+7.1%+3.8%
Q4 2024+6.7%+0.5%-6.8%
Q3 2024-29.5%-36.7%-36.2%
Q2 2024-3.1%-11.9%-24.0%
Q1 2024-9.3%+3.4%-10.1%
Q4 2023-20.9%-25.5%-24.7%
Q3 2023-12.2%-17.7%-9.5%
Q2 2023-16.4%-16.6%-18.6%
Q1 2023+7.7%+10.3%+18.0%
Q4 2022-4.0%-2.3%-13.4%
Q3 2022-7.5%-0.4%+1.7%
Q2 2022+1.8%-1.7%-12.7%
Q1 2022-8.2%-10.6%-1.3%
Q4 2021+8.8%+5.3%+10.4%
Q3 2021-8.2%-1.4%+3.7%
Q2 2021+5.4%+3.8%+15.4%
Q1 2021+7.6%+10.3%+11.0%
Q4 2020+4.1%-0.7%+1.4%
Q3 2020-5.8%-7.0%-1.9%
Q2 2020+4.8%-4.5%-1.7%
Q1 2020-9.3%-12.1%+13.0%
Q4 2019+9.6%+5.6%+4.0%
Q3 2019-0.5%+2.1%+0.8%
Q2 2019+7.7%+11.4%+15.5%
Q1 2019+1.9%-0.4%-6.0%
Q4 2018-12.5%-14.7%-26.7%
Q3 2018+13.3%+11.6%+23.9%
Q2 2018-15.2%-10.4%-5.4%
Q1 2018-21.9%-21.6%-14.6%
Q4 2017+4.8%+4.8%+10.9%
Q3 2017-3.6%-1.6%+16.3%
Q2 2017+1.1%+6.9%+4.4%
Q1 2017-6.8%-6.2%-9.0%
Q4 2016+4.0%+7.9%+10.3%
Q3 2016-1.6%-2.7%-7.8%
Q2 2016-11.9%-13.8%-13.5%
Q1 2016+1.0%
Q4 2015+1.8%
Q3 2015+5.9%
Q2 2015+0.1%
Q1 2015-1.4%
Q4 2014+2.0%
Q3 2014-1.7%
Q2 2014+5.7%
Q1 2014+3.8%
Q4 2013+1.4%
Q4 2012+13.4%
Q3 2013+13.4%
Q2 2013+6.1%
Q1 2013-1.3%
Q3 2012+4.0%
Q2 2012+5.5%
Q1 2011+19.4%
Q1 2012+6.1%
Q4 2011-2.0%
Q4 2009-2.0%
Q3 2011-3.7%
Q3 2010-3.7%
Q4 2010-1.4%
Q2 2010-1.4%
Q2 2011-1.4%
Q1 2010-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro